查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1590369

全球醫療營養市場：產業分析、規模、佔有率、成長、趨勢、預測（2024-2031）

Advanced Medical Nutrition Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2031
出版日期: | 出版商: Persistence Market Research | 英文 147 Pages | 商品交期: 2-5個工作天內

價格
簡介目錄

本報告審視了全球醫療營養市場，並按營養類型、產品類型、分銷管道、區域趨勢以及參與市場的公司概況提供了趨勢。

目錄

第 1 章執行摘要

第二章市場介紹

第三章醫療營養市場分析

  • 價格分析

第四章醫療營養市場動態

  • 宏觀經濟因素
  • 促進因素
  • 阻礙因素
  • 機會
  • 世界市場趨勢
  • 歐洲的採購流程：HealthTrust Europe (HTE)
  • 歐洲採購流程：歐洲藥品管理局 (EMA)
  • 採購和投標流程的重要見解
  • 最佳實務步驟：養分供應採購流程
  • 主要見解：腸外營養市場
  • 監理事實：腸外營養

第五章全球醫療營養市場分析與預測：依營養類型

第六章全球醫療營養市場分析與預測：依產品類型

  • 簡介
  • 市場預測：依產品類型
  • 市場吸引力分析：依產品類型
  • 值得注意的市場趨勢

第七章全球醫療營養市場分析與預測：依通路分割

  • 簡介
  • 市場預測：依通路劃分
  • 市場吸引力分析：按分銷管道

第 8 章全球醫療營養市場分析與預測：按地區

  • 簡介
  • 市場預測：依地區劃分
  • 市場吸引力分析：依地區劃分

第九章北美醫療營養市場分析與預測

第10章拉丁美洲醫療營養市場分析與預測

第十一章歐洲醫療營養市場分析與預測

第十二章亞太醫療營養市場分析與預測

第十三章中東及非洲醫療營養市場分析與預測

第14章競爭態勢

  • 競爭對手儀表板
  • 公司市佔率分析：依地區劃分
  • 世界複合腸外營養公司佔有率
  • 公司簡介（詳細資料 - 概述、財務狀況、策略、近期趨勢、SWOT 分析）
    • Allergan
    • Baxter International Inc.
    • B. Braun Melsungen AG.
    • Fresenius Kabi AG
    • Pfizer, Inc.
    • Sanofi
    • Mead Johnson & Company, LLC
    • Sichuan Kelun Pharmaceutical Company Limited
    • Otsuka Pharmaceuticals Co., Ltd.
    • Grifols S.A.
    • Abbott Laboratories
    • Danone Nutricia
    • Demo S.A. Pharmaceutical Industry

第 15 章使用的假設與縮寫

第十六章研究方法

簡介目錄
Product Code: PMRREP16588

Persistence Market Research has recently released a comprehensive report on the global Advanced Medical Nutrition Market. This report provides an in-depth evaluation of critical market dynamics, including drivers, trends, opportunities, and challenges, delivering detailed insights into the market structure.

Key Insights:

  • Advanced Medical Nutrition Market Size (2024E): USD 49.2 Bn
  • Projected Market Value (2031F): USD 93.5 Bn
  • Global Market Growth Rate (CAGR 2024 to 2031): 9.6%

Advanced Medical Nutrition Market - Report Scope:

The Advanced Medical Nutrition market encompasses specialized products that provide therapeutic nutrition support to individuals facing specific health conditions or requiring nutritional intervention. These products include enteral and parenteral nutrition solutions, as well as supplements specifically formulated for clinical nutrition needs. They cater to a range of consumers, including patients with chronic illnesses, elderly individuals, and malnourished populations. Market growth is driven by an increasing prevalence of chronic diseases, an aging population, and a heightened awareness of clinical nutrition's role in managing health.

Market Growth Drivers:

The global Advanced Medical Nutrition market is propelled by multiple factors. The rising prevalence of chronic conditions such as diabetes, cancer, and gastrointestinal disorders has led to increased demand for clinical nutrition products designed to support patient health. Additionally, the aging population, especially in developed countries, creates a high demand for advanced medical nutrition to address age-related health issues. Technological advancements in the formulation of medical nutrition, including improved ingredient sourcing and specialized formulations for targeted therapies, also play a significant role in driving market expansion.

Market Restraints:

Despite its promising growth trajectory, the Advanced Medical Nutrition market faces certain challenges. High costs associated with medical nutrition products can limit their accessibility, particularly in low-income regions. Regulatory constraints and stringent quality control measures required for medical nutrition products can delay market entry for new players. Additionally, limited awareness of medical nutrition's benefits among patients and healthcare providers in certain areas poses a challenge. Addressing these issues requires investment in R&D, regulatory navigation, and effective marketing to educate stakeholders about the value of medical nutrition.

Market Opportunities:

The Advanced Medical Nutrition market presents substantial growth opportunities, driven by ongoing research and development and the expansion of applications in various healthcare settings. Emerging markets are showing increased interest in medical nutrition as a preventive and therapeutic tool. Collaborations with healthcare institutions and strategic partnerships with hospitals and clinics provide a pathway for growth. Innovations in product formulations, including personalized nutrition solutions, further expand market possibilities. The development of cost-effective products and investment in sustainable production methods are critical for capitalizing on these opportunities.

Key Questions Answered in the Report:

  • What are the main factors driving growth in the global Advanced Medical Nutrition market?
  • Which healthcare segments are leading the adoption of medical nutrition products?
  • How are technological advancements shaping the competitive landscape of the Advanced Medical Nutrition market?
  • Who are the major players in the Advanced Medical Nutrition market, and what strategies are they using to stay competitive?
  • What are the emerging trends and future outlook in the global Advanced Medical Nutrition market?

Competitive Intelligence and Business Strategy:

Leading companies in the global Advanced Medical Nutrition market, including Abbott Laboratories, Nestle Health Science, and Danone, prioritize innovation, product differentiation, and strategic alliances to maintain a competitive edge. These companies focus on R&D to develop advanced and specialized products catering to specific health conditions, such as oncology and geriatric nutrition. Collaborations with healthcare providers and institutions facilitate the development of tailored solutions for various patient needs. A strong emphasis on regulatory compliance, quality assurance, and effective marketing strategies ensures the credibility and adoption of medical nutrition products globally.

Key Companies Profiled:

  • Allergan
  • Baxter International Inc.
  • Braun Melsungen AG.
  • Fresenius Kabi AG
  • Pfizer, Inc.
  • Sanofi
  • Mead Johnson & Company, LLC

Advanced Medical Nutrition Industry Segmentation:

By Nutrition Type

  • Parenteral
  • Enteral
  • Oral

By Product Type

  • Amino Acid Solutions
  • Multiple Vitamins and Antioxidants
  • Lipid Emulsions
  • Trace Elements
  • 2C Bags
  • 3C Bags

By Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Compounding Pharmacies
  • Others

By Region

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East & Africa

Table of Contents

1. Executive Summary

2. Market Introduction

  • 2.1. Market Definition
  • 2.2. Market Taxonomy
  • 2.3. Market Overview

3. Medical Nutrition Market Analysis

  • 3.1. Pricing Analysis
    • 3.1.1. Price Projections By Region

4. Medical Nutrition Market Dynamics

  • 4.1. Macro-economic Factors
  • 4.2. Drivers
    • 4.2.1. Supply Side
    • 4.2.2. Demand Side
  • 4.3. Restraints
  • 4.4. Opportunity
  • 4.5. Global Market Trends
  • 4.6. Procurement Process in Europe : HealthTrust Europe (HTE)
  • 4.7. Procurement Process in Europe : European Medicines Agency (EMA)
  • 4.8. Primary Insights on Procurement and Tender Process
  • 4.9. Best Practice Steps : Procurement Process of Nutrition Supply
  • 4.10. Key Insights: Parenteral Nutrition Market
  • 4.11. Regulatory Facts: Parenteral Nutrition

5. Global Medical Nutrition Market Analysis and Forecast, By Nutrition Type

  • 5.1. Introduction
    • 5.1.1. Market share and Basis Points (BPS) Analysis By Nutrition Type

6. Global Medical Nutrition Market Analysis and Forecast, By Product Type

  • 6.1. Introduction
    • 6.1.1. Market share and Basis Points (BPS) Analysis By Product Type
    • 6.1.2. Y-o-Y Growth Projections By Product Type
  • 6.2. Market Size (US$ Bn) Forecast, By Product Type
    • 6.2.1. Amino Acid Solutions
    • 6.2.2. Multiple Vitamins and Antioxidants
    • 6.2.3. Lipid Emulsions
    • 6.2.4. Trace Elements
    • 6.2.5. 2C Bags
    • 6.2.6. 3C Bags
  • 6.3. Market Attractiveness Analysis By Product Type
  • 6.4. Prominent Market Trends

7. Global Medical Nutrition Market Analysis and Forecast, By Distribution Channel

  • 7.1. Introduction
    • 7.1.1. Market share and Basis Points (BPS) Analysis By Distribution Channel
    • 7.1.2. Y-o-Y Growth Projections By Distribution Channel
  • 7.2. Market Size (US$ Bn) Forecast By Distribution Channel
    • 7.2.1. Hospital Pharmacies
    • 7.2.2. Retail Pharmacies
    • 7.2.3. Compound Pharmacies
    • 7.2.4. Others
  • 7.3. Market Attractiveness Analysis By Distribution Channel

8. Global Medical Nutrition Market Analysis and Forecast, By Region

  • 8.1. Introduction
    • 8.1.1. Market share and Basis Points (BPS) Analysis By Region
    • 8.1.2. Y-o-Y Growth Projections By Region
  • 8.2. Market Size (US$ Bn) Forecast By Region
    • 8.2.1. North America
    • 8.2.2. Europe
    • 8.2.3. Asia Pacific
    • 8.2.4. Latin America
    • 8.2.5. Middle East and Africa (MEA)
  • 8.3. Market Attractiveness Analysis By Region

9. North America Medical Nutrition Market Analysis Historic and Forecast

  • 9.1. Introduction
    • 9.1.1. Market share and Basis Points (BPS) Analysis By Country
    • 9.1.2. Y-o-Y Growth Projections By Country
    • 9.1.3. Key Regulations
  • 9.2. Market Size (US$ Bn) Forecast By Country
    • 9.2.1. U.S.
    • 9.2.2. Canada
  • 9.3. Market Size (US$ Bn) Forecast, By Product Type
    • 9.3.1. Amino Acid Solutions
    • 9.3.2. Multiple Vitamins and Antioxidants
    • 9.3.3. Lipid Emulsions
    • 9.3.4. Trace Elements
    • 9.3.5. 2C Bags
    • 9.3.6. 3C Bags
  • 9.4. Market Size (US$ Bn) Forecast By Distribution Channel
    • 9.4.1. Hospital Pharmacies
    • 9.4.2. Retail Pharmacies
    • 9.4.3. Compound Pharmacies
    • 9.4.4. Others
  • 9.5. Market Attractiveness Analysis
    • 9.5.1. By Country
    • 9.5.2. By Product Type
    • 9.5.3. By Distribution Channel

10. Latin America Medical Nutrition Market Analysis Historic and Forecast

  • 10.1. Introduction
    • 10.1.1. Market share and Basis Points (BPS) Analysis By Country
    • 10.1.2. Y-o-Y Growth Projections By Country
    • 10.1.3. Key Regulations
  • 10.2. Market Size (US$ Bn) Forecast By Country
    • 10.2.1. Brazil
    • 10.2.2. Mexico
    • 10.2.3. Rest of Latin America
  • 10.3. Market Size (US$ Bn) Forecast, By Product Type
    • 10.3.1. Amino Acid Solutions
    • 10.3.2. Multiple Vitamins and Antioxidants
    • 10.3.3. Lipid Emulsions
    • 10.3.4. Trace Elements
    • 10.3.5. 2C Bags
    • 10.3.6. 3C Bags
  • 10.4. Market Size (US$ Bn) Forecast By Distribution Channel
    • 10.4.1. Hospital Pharmacies
    • 10.4.2. Retail Pharmacies
    • 10.4.3. Compound Pharmacies
    • 10.4.4. Others
  • 10.5. Market Attractiveness Analysis
    • 10.5.1. By Country
    • 10.5.2. By Product Type
    • 10.5.3. By Distribution Channel

11. Europe Medical Nutrition Market Analysis Historic and Forecast

  • 11.1. Introduction
    • 11.1.1. Market share and Basis Points (BPS) Analysis By Country
    • 11.1.2. Y-o-Y Growth Projections By Country
    • 11.1.3. Key Regulations
  • 11.2. Market Size (US$ Bn) Forecast By Country
    • 11.2.1. Germany
    • 11.2.2. Spain
    • 11.2.3. Italy
    • 11.2.4. France
    • 11.2.5. U.K.
    • 11.2.6. Russia
    • 11.2.7. Rest of Europe
  • 11.3. Market Size (US$ Bn) Forecast, By Product Type
    • 11.3.1. Amino Acid Solutions
    • 11.3.2. Multiple Vitamins and Antioxidants
    • 11.3.3. Lipid Emulsions
    • 11.3.4. Trace Elements
    • 11.3.5. 2C Bags
    • 11.3.6. 3C Bags
  • 11.4. Market Size (US$ Bn) Forecast By Distribution Channel
    • 11.4.1. Hospital Pharmacies
    • 11.4.2. Retail Pharmacies
    • 11.4.3. Compound Pharmacies
    • 11.4.4. Others
  • 11.5. Market Attractiveness Analysis
    • 11.5.1. By Country
    • 11.5.2. By Product Type
    • 11.5.3. By Distribution Channel

12. Asia Pacific Medical Nutrition Market Analysis Historic and Forecast

  • 12.1. Introduction
    • 12.1.1. Market share and Basis Points (BPS) Analysis By Country
    • 12.1.2. Y-o-Y Growth Projections By Country
    • 12.1.3. Key Regulations
  • 12.2. Market Size (US$ Bn) Forecast By Country
    • 12.2.1. China
    • 12.2.2. India
    • 12.2.3. Japan
    • 12.2.4. ASEAN
    • 12.2.5. Australia and New Zealand
    • 12.2.6. Rest of APAC
  • 12.3. Market Size (US$ Bn) Forecast, By Product Type
    • 12.3.1. Amino Acid Solutions
    • 12.3.2. Multiple Vitamins and Antioxidants
    • 12.3.3. Lipid Emulsions
    • 12.3.4. Trace Elements
    • 12.3.5. 2C Bags
    • 12.3.6. 3C Bags
  • 12.4. Market Size (US$ Bn) Forecast By Distribution Channel
    • 12.4.1. Hospital Pharmacies
    • 12.4.2. Retail Pharmacies
    • 12.4.3. Compound Pharmacies
    • 12.4.4. Others
  • 12.5. Market Attractiveness Analysis
    • 12.5.1. By Country
    • 12.5.2. By Product Type
    • 12.5.3. By Distribution Channel

13. Middle East and Africa Medical Nutrition Market Analysis Historic and Forecast

  • 13.1. Introduction
    • 13.1.1. Market share and Basis Points (BPS) Analysis By Country
    • 13.1.2. Y-o-Y Growth Projections By Country
    • 13.1.3. Key Regulations
  • 13.2. Market Size (US$ Bn) Forecast By Country
    • 13.2.1. North Africa
    • 13.2.2. South Africa
    • 13.2.3. GCC countries
    • 13.2.4. Rest of MEA
  • 13.3. Market Size (US$ Bn) Forecast, By Product Type
    • 13.3.1. Amino Acid Solutions
    • 13.3.2. Multiple Vitamins and Antioxidants
    • 13.3.3. Lipid Emulsions
    • 13.3.4. Trace Elements
    • 13.3.5. 2C Bags
    • 13.3.6. 3C bags
  • 13.4. Market Size (US$ Bn) Forecast By Distribution Channel
    • 13.4.1. Hospital Pharmacies
    • 13.4.2. Retail Pharmacies
    • 13.4.3. Compound Pharmacies
    • 13.4.4. Others
  • 13.5. Market Attractiveness Analysis
    • 13.5.1. By Country
    • 13.5.2. By Product Type
    • 13.5.3. By Distribution Channel

14. Competitive Landscape

  • 14.1. Competition Dashboard
  • 14.2. Company Market Share Analysis By Region
  • 14.3. Global Compounding Parenteral Nutrition Company Share
  • 14.4. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments, SWOT analysis)
    • 14.4.1. Allergan
    • 14.4.2. Baxter International Inc.
    • 14.4.3. B. Braun Melsungen AG.
    • 14.4.4. Fresenius Kabi AG
    • 14.4.5. Pfizer, Inc.
    • 14.4.6. Sanofi
    • 14.4.7. Mead Johnson & Company, LLC
    • 14.4.8. Sichuan Kelun Pharmaceutical Company Limited
    • 14.4.9. Otsuka Pharmaceuticals Co., Ltd.
    • 14.4.10. Grifols S.A.
    • 14.4.11. Abbott Laboratories
    • 14.4.12. Danone Nutricia
    • 14.4.13. Demo S.A. Pharmaceutical Industry

15. Assumptions and Acronyms Used

16. Research Methodology